Postoperative concurrent daily low-dose cisplatin-based chemoradiation improves the prognosis of patients with pathologic T2b or N1 cervical cancer
Postoperative concurrent daily low-dose cisplatin-based chemoradiation improves the prognosis of patients with pathologic T2b or N1 cervical cancer
复制标题
术后每日同步低剂量顺铂化放疗可改善病理性 T2b 或 N1 宫颈癌患者的预后
作者：
Mitsuhashi A;Uno T;Usui H;Tate S;Hirashiki K;Kato K;Kiyohara H;Kato S;Ito H;Shozu M
